Entrada Therapeutics (TRDA) Earnings (2020 - 2026)
Entrada Therapeutics (TRDA) earnings from Mar 31, 2020 to Mar 31, 2026. The TTM Entrada Therapeutics (TRDA) earnings is -$166M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Entrada Therapeutics (TRDA) Earnings CAGR table
| Period | CAGR |
|---|---|
| 3 Years TTM | +27.78% |
| 5 Years TTM | +40.62% |
| All Time TTM | +40.63% |
Annual Earnings change of Entrada Therapeutics (TRDA)
| Year | Earnings | Change |
|---|---|---|
| 2026 | -$40M | -72.37% |
| 2025 | -$144M | -319.03% |
| 2024 | $66M | -1082.49% |
| 2023 | -$6.68M | -92.94% |
| 2022 | -$95M | +84.95% |
| 2021 | -$51M | +92.91% |
| 2020 | -$27M | N/A |
Comparison Entrada Therapeutics (TRDA) five years earnings CAGR with competitors
Entrada Therapeutics (TRDA) five years earnings CAGR is 40.62%.